Previous close | 78.26 |
Open | 79.19 |
Bid | 77.50 x 600 |
Ask | 84.51 x 200 |
Day's range | 77.19 - 79.34 |
52-week range | 62.35 - 94.50 |
Volume | |
Avg. volume | 3,785,877 |
Market cap | 35.636B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 22.69 |
EPS (TTM) | 3.44 |
Earnings date | N/A |
Forward dividend & yield | 0.12 (0.15%) |
Ex-dividend date | 18 Apr 2024 |
1y target est | 93.71 |
GE HealthCare Technologies ( NASDAQ:GEHC ) First Quarter 2024 Results Key Financial Results Revenue: US$4.65b (down...
CHICAGO, May 01, 2024--GE HealthCare (Nasdaq: GEHC) today announced Revolution RT,i a new radiation therapy computed tomography (CT) solution with innovative hardware and software solutions to help increase imaging accuracy, while simplifying simulation workflow for a more personalized and seamless oncology care pathway experience for clinicians and patients. The new Revolution RT is being unveiled at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2024 Congress in Glasgow, a
GE HealthCare Technologies' (GEHC) shares experienced a sharp decline in Tuesday's afternoon trading session, as the company's first quarterly report since its 2023 spinoff from General Electric fell short of revenue estimates. The company saw revenue drop 1% year-over-year, fueling a sell-off among investors. Yahoo Finance Health Reporter Anjalee Khemlani breaks down the report. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Angel Smith